{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T02:18:33Z","timestamp":1785809913403,"version":"3.56.0"},"posted":{"date-parts":[[2025,10,28]]},"group-title":"Radiology and Imaging","reference-count":38,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.medrxiv.org\/about\/FAQ#license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,10,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Immunotherapy has improved outcomes for advanced-stage melanoma, however, predictive biomarkers remain limited. We evaluated whether computed tomography (CT) features from multiple anatomical regions could predict immunotherapy response.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Materials and Methods<\/jats:title>\n                  <jats:p>This study included 157 advanced cutaneous melanoma patients (mean age: 63.3 years; 65.6% male) treated with PD-1 immune checkpoint inhibitor (ICI) singly or in combination with LAG-3 or CTLA-4 ICIs. The primary outcome was 1-year progression-free survival (PFS \u226512 months). Available artificial intelligence (AI) algorithms were applied to pretreatment CT scans to extract and quantify three-dimensional (3D) body composition and thoracic features across abdominal, chest, pelvic regions, and spinal vertebrae. Feature relationship to PFS was assessed. Machine learning (ML) models were used to predict PFS, utilizing only the most important five features to mitigate overfitting. Prediction performance was evaluated using the area under the receiver operating curve (AUROC) with stratified 10-fold cross-validation.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Multiple CT features are significantly associated with immunotherapy response. Body tissues at the L5 spinal vertebrae emerged as key predictors. A random forest classifier (RFC) trained on three CT features (L5 bone volume, L5 subcutaneous adipose tissue volume, pelvis visceral adipose tissue density) and two clinical variables achieved a mean AUROC of 0.83 (95% CI: 0.72\u20130.94). A logistic regression model using the same features yielded an AUROC of 0.82 (95% CI: 0.74\u20130.91), significantly outperforming a clinical-only model (AUROC 0.65; 95% CI: 0.56\u20130.74; p=0.006).<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Integrating imaging features from multiple anatomical regions can improve the prediction of immunotherapy response in advanced melanoma.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2025.10.26.25338837","type":"posted-content","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T01:15:18Z","timestamp":1761700518000},"source":"Crossref","is-referenced-by-count":1,"title":["Multiregional CT Features Improve Prediction of Immunotherapy Response in Advanced Melanoma"],"prefix":"10.64898","author":[{"given":"Grant","family":"Kokenberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jatin","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Hurd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter J.","family":"Storkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason J.","family":"Luke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana G.","family":"Najjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M","family":"Kirkwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassane M","family":"Zarour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diwakar","family":"Davar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiantao","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2025103004101181000_2025.10.26.25338837v1.1","doi-asserted-by":"publisher","DOI":"10.1038\/70932"},{"key":"2025103004101181000_2025.10.26.25338837v1.2","doi-asserted-by":"publisher","DOI":"10.1038\/85330"},{"key":"2025103004101181000_2025.10.26.25338837v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(95)90125-6"},{"key":"2025103004101181000_2025.10.26.25338837v1.4","doi-asserted-by":"publisher","DOI":"10.1126\/science.270.5238.985"},{"key":"2025103004101181000_2025.10.26.25338837v1.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA2407417"},{"key":"2025103004101181000_2025.10.26.25338837v1.6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.3384"},{"key":"2025103004101181000_2025.10.26.25338837v1.7","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz108"},{"key":"2025103004101181000_2025.10.26.25338837v1.8","doi-asserted-by":"crossref","unstructured":"Chen X , Zhou M , Wang Z , Lu S , Chang S , Zhou Z . Immunotherapy treatment outcome prediction in metastatic melanoma through an automated multi-objective delta-radiomics model. Comput Biol Med. 2021;138:104916.","DOI":"10.1016\/j.compbiomed.2021.104916"},{"key":"2025103004101181000_2025.10.26.25338837v1.9","doi-asserted-by":"crossref","unstructured":"Flaus A , Habouzit V , de Leiris N , Vuillez JP , Leccia MT , Simonson M , et al. Outcome Prediction at Patient Level Derived from Pre-Treatment 18F-FDG PET Due to Machine Learning in Metastatic Melanoma Treated with Anti-PD1 Treatment. Diagnostics (Basel). 2022;12(2).","DOI":"10.3390\/diagnostics12020388"},{"key":"2025103004101181000_2025.10.26.25338837v1.10","doi-asserted-by":"crossref","unstructured":"Kuang T , Zhang L , Qiu Z , Zhang Y , Wang W . Prognostic value of body composition on survival outcomes in melanoma patients receiving immunotherapy. Front Immunol. 2023;14:1261202.","DOI":"10.3389\/fimmu.2023.1261202"},{"issue":"Suppl 1","key":"2025103004101181000_2025.10.26.25338837v1.11","first-page":"S257","article-title":"Subcutaneous Fat Abundance and Density Are Associated with an Enhanced Response to Immunotherapy in Metastatic Melanoma: A Retrospective Cohort Study","volume":"30","year":"2023","journal-title":"Acad Radiol"},{"issue":"66","key":"2025103004101181000_2025.10.26.25338837v1.12","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/jncimonographs\/lgad034","volume":"2024","author":"Correction to: Imaging modalities for measuring body composition in patients with cancer: opportunities and challenges","year":". 2024","journal-title":"J Natl Cancer Inst Monogr"},{"key":"2025103004101181000_2025.10.26.25338837v1.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"2025103004101181000_2025.10.26.25338837v1.14","doi-asserted-by":"publisher","DOI":"10.1002\/mp.15932"},{"key":"2025103004101181000_2025.10.26.25338837v1.15","doi-asserted-by":"publisher","DOI":"10.1002\/mp.15821"},{"key":"2025103004101181000_2025.10.26.25338837v1.16","doi-asserted-by":"crossref","unstructured":"Pu J , Leader JK , Sechrist J , Beeche CA , Singh JP , Ocak IK , et al. Automated identification of pulmonary arteries and veins depicted in non-contrast chest CT scans. Med Image Anal. 2022;77:102367.","DOI":"10.1016\/j.media.2022.102367"},{"key":"2025103004101181000_2025.10.26.25338837v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.compmedimag.2008.04.005"},{"key":"2025103004101181000_2025.10.26.25338837v1.18","doi-asserted-by":"publisher","DOI":"10.1161\/circimaging.122.015159"},{"key":"2025103004101181000_2025.10.26.25338837v1.19","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-022-00679-9"},{"issue":"5","key":"2025103004101181000_2025.10.26.25338837v1.20","first-page":"051806","article-title":"Predicting left\/right lung volumes, thoracic cavity volume, and heart volume from subject demographics to improve lung transplant","volume":"10","year":"2023","journal-title":"J Med Imaging (Bellingham"},{"key":"2025103004101181000_2025.10.26.25338837v1.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2016.10.002"},{"key":"2025103004101181000_2025.10.26.25338837v1.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2023.02.010"},{"issue":"4","key":"2025103004101181000_2025.10.26.25338837v1.23","first-page":"e2021106","article-title":"Body Mass Index and Melanoma Prognosis","volume":"11","year":"2021","journal-title":"Dermatol Pract Concept"},{"issue":"1","key":"2025103004101181000_2025.10.26.25338837v1.24","first-page":"5","article-title":"Prognostic value of obesity in patients with cancer treated with immune checkpoint inhibitors: An updated meta analysis and systematic review","volume":"20","year":"2024","journal-title":"Mol Clin Oncol"},{"key":"2025103004101181000_2025.10.26.25338837v1.25","doi-asserted-by":"crossref","unstructured":"Lee JH , Hyung S , Lee J , Choi SH . Visceral adiposity and systemic inflammation in the obesity paradox in patients with unresectable or metastatic melanoma undergoing immune checkpoint inhibitor therapy: a retrospective cohort study. J Immunother Cancer. 2022;10(8).","DOI":"10.1136\/jitc-2022-005226"},{"key":"2025103004101181000_2025.10.26.25338837v1.26","doi-asserted-by":"crossref","unstructured":"Decazes P , Ammari S , Belkouchi Y , Mottay L , Lawrance L , de Previa A , et al. Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer. J Immunother Cancer. 2023;11(9).","DOI":"10.1136\/jitc-2023-007315"},{"key":"2025103004101181000_2025.10.26.25338837v1.27","doi-asserted-by":"crossref","unstructured":"Young AC , Quach HT , Song H , Davis EJ , Moslehi JJ , Ye F , et al. Impact of body composition on outcomes from anti-PD1 +\/-anti-CTLA-4 treatment in melanoma. J Immunother Cancer. 2020;8(2).","DOI":"10.1136\/jitc-2020-000821"},{"key":"2025103004101181000_2025.10.26.25338837v1.28","doi-asserted-by":"crossref","unstructured":"Faron A , Opheys NS , Nowak S , Sprinkart AM , Isaak A , Theis M , et al. Deep Learning-Based Body Composition Analysis Predicts Outcome in Melanoma Patients Treated with Immune Checkpoint Inhibitors. Diagnostics (Basel). 2021;11(12).","DOI":"10.3390\/diagnostics11122314"},{"key":"2025103004101181000_2025.10.26.25338837v1.29","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1475"},{"key":"2025103004101181000_2025.10.26.25338837v1.30","doi-asserted-by":"crossref","unstructured":"Guo Y , Xiang D , Wan J , Yang L , Zheng C . Focus on the Dynamics of Neutrophil-to-Lymphocyte Ratio in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Meta-Analysis and Systematic Review. Cancers (Basel). 2022;14(21).","DOI":"10.3390\/cancers14215297"},{"issue":"Suppl 2","key":"2025103004101181000_2025.10.26.25338837v1.31","first-page":"A634","article-title":"557 Clinical response to immune checkpoint inhibitor therapy in metastatic and unresectable NF1 mutated cutaneous melanoma","volume":"12","year":"2024","journal-title":"Journal for ImmunoTherapy of Cancer"},{"key":"2025103004101181000_2025.10.26.25338837v1.32","doi-asserted-by":"crossref","unstructured":"Rugambwa TK , Abdihamid O , Zhang X , Peng Y , Cai C , Shen H , et al. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as potential predictive markers of treatment response in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis. Front Oncol. 2023;13:1181248.","DOI":"10.3389\/fonc.2023.1181248"},{"issue":"2","key":"2025103004101181000_2025.10.26.25338837v1.33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.pathol.2023.11.004","article-title":"Prognostic and predictive biomarkers in melanoma","volume":"56","year":"2024","journal-title":"Pathology"},{"key":"2025103004101181000_2025.10.26.25338837v1.34","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-2415"},{"key":"2025103004101181000_2025.10.26.25338837v1.35","doi-asserted-by":"crossref","unstructured":"Li J , Dan K , Ai J . Machine learning in the prediction of immunotherapy response and prognosis of melanoma: a systematic review and meta-analysis. Front Immunol. 2024;15:1281940.","DOI":"10.3389\/fimmu.2024.1281940"},{"key":"2025103004101181000_2025.10.26.25338837v1.36","doi-asserted-by":"crossref","unstructured":"Cao K , Yeung J , Arafat Y , Wei MYK , Yeung JMC , Baird PN . Identification of Differences in Body Composition Measures Using 3D-Derived Artificial Intelligence from Multiple CT Scans across the L3 Vertebra Compared to a Single Mid-Point L3 CT Scan. Radiol Res Pract. 2023;2023:1047314.","DOI":"10.1155\/2023\/1047314"},{"key":"2025103004101181000_2025.10.26.25338837v1.37","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejca.2020.12.028","article-title":"Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis","volume":"145","year":"2021","journal-title":"Eur J Cancer"},{"key":"2025103004101181000_2025.10.26.25338837v1.38","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glt070"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.10.26.25338837","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:49:44Z","timestamp":1768510184000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2025.10.26.25338837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":38,"URL":"https:\/\/doi.org\/10.1101\/2025.10.26.25338837","relation":{},"subject":[],"published":{"date-parts":[[2025,10,28]]},"subtype":"preprint"}}